NeuroSense Therapeutics Ltd.
Price Action
Technical Summary
WEAKENINGNeuroSense Therapeutics Ltd. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 36), showing significant lag compared to the market leaders. Earnings contraction of 95% provides fundamental context to the price action. Investors should exercise caution due to high volatility (96% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.78 | +12.96% | ABOVE |
| 50 SMA | $0.79 | +10.33% | ABOVE |
| 100 SMA | $0.85 | +2.92% | ABOVE |
| 150 SMA | $0.94 | -6.55% | BELOW |
| 200 SMA | $1.03 | -14.71% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NRSN in an uptrend right now?
NRSN has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is NRSN overbought or oversold?
NRSN's RSI (14) is 63. The stock is in neutral territory, neither overbought nor oversold.
Is NRSN outperforming the market?
NRSN has a Relative Strength (RS) Rating of 36 out of 99. NRSN is currently lagging the broader market.
Where is NRSN in its 52-week range?
NRSN is trading at $0.88, which is 34% of its 52-week high ($2.60) and 13% above its 52-week low ($0.63).
How volatile is NRSN?
NRSN has a Beta of 1.27 and 52-week volatility of 96%. It's more volatile than the S&P 500 - expect bigger swings.